---
figid: PMC5453110__ol-13-06-4577-g00
figtitle: IL-8/IL-8R axis
organisms:
- Homo sapiens
pmcid: PMC5453110
filename: ol-13-06-4577-g00.jpg
figlink: /pmc/articles/PMC5453110/figure/f1-ol-0-0-6034/
number: F1
caption: IL-8/IL-8R axis. IL-8 is able to induce EMT and promote tumor progression.
  There are important associations between IL-8/IL-8R and EMT in cancer patients.
  The IL-8/IL-8R signaling pathway is able to induce IL-8 overexpression, which is
  closely correlated with poor prognosis. ATF-2, activating transcription factor-2;
  CXCR1/2, IL-8 receptor type 1/2; EMT, epithelial-mesenchymal transition; ERK, extracellular
  signal-regulated kinase; IL, interleukin; NF-κB, nuclear factor-κB; JNK, Jun N-terminal
  kinase; MMP, matrix metalloprotease; PI3K, phosphatidyl inositol 3-kinase; PTEN,
  phosphatase and tensin homolog; Syk, spleen associated tyrosine kinase; TGFβ, transforming
  growth factor β; VEGFR, vascular endothelial growth factor receptor; ZEB1, zinc
  finger e-box binding homeobox 1.
papertitle: 'Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.'
reftext: Zhiwei Zhao, et al. Oncol Lett. 2017 Jun;13(6):4577-4584.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.942175
figid_alias: PMC5453110__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5453110__F1
ndex: 278ca009-df01-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5453110__ol-13-06-4577-g00.html
  '@type': Dataset
  description: IL-8/IL-8R axis. IL-8 is able to induce EMT and promote tumor progression.
    There are important associations between IL-8/IL-8R and EMT in cancer patients.
    The IL-8/IL-8R signaling pathway is able to induce IL-8 overexpression, which
    is closely correlated with poor prognosis. ATF-2, activating transcription factor-2;
    CXCR1/2, IL-8 receptor type 1/2; EMT, epithelial-mesenchymal transition; ERK,
    extracellular signal-regulated kinase; IL, interleukin; NF-κB, nuclear factor-κB;
    JNK, Jun N-terminal kinase; MMP, matrix metalloprotease; PI3K, phosphatidyl inositol
    3-kinase; PTEN, phosphatase and tensin homolog; Syk, spleen associated tyrosine
    kinase; TGFβ, transforming growth factor β; VEGFR, vascular endothelial growth
    factor receptor; ZEB1, zinc finger e-box binding homeobox 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - ITK
  - SLC22A3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - TGFB1
  - TGFB2
  - TGFB3
  - KDR
  - FLT1
  - FLT4
  - CTNNB1
  - SYK
  - SRC
  - FGR
  - FYN
  - YES1
  - CXCR1
  - CXCR2
  - CXCL8
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - SNAI1
  - ZEB1
  - EPHB2
  - MAPK1
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - AKT1
  - AKT2
  - AKT3
  - ATF2
  - GDNF
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - Cancer
---
